Department of Environmental Medicine, New York University Langone Medical Center, Tuxedo, New York.
Mol Pharmacol. 2014 May;85(5):651-7. doi: 10.1124/mol.113.089623. Epub 2014 Feb 25.
Cellular response to changes in oxygen tension during normal development or pathologic processes is, in part, regulated by hypoxia-inducible factor (HIF), an oxygen-sensitive transcription factor. HIF activity is primarily controlled through post-translational modifications and stabilization of HIF-1α and HIF-2α proteins and is regulated by a number of cellular pathways involving both oxygen-dependent and -independent mechanisms. Stabilization of HIF-1α activates transcription of genes that participate in key pathways in carcinogenesis, such as angiogenesis, dedifferentiation, and invasion. Since its discovery more than two decades ago, HIF-1α has become a hot topic in molecular research and has been implicated not only in disease pathology but also in prognosis. In this review, we will focus on recent insights into HIF-1α regulation, function, and gene expression. We will also discuss emerging data on the involvement of HIF in cancer prognosis and therapeutic interventions.
细胞对正常发育或病理过程中氧张力变化的反应部分受缺氧诱导因子(HIF)的调节,HIF 是一种氧敏感转录因子。HIF 活性主要通过 HIF-1α 和 HIF-2α 蛋白的翻译后修饰和稳定来控制,并且受到涉及氧依赖和非依赖机制的许多细胞途径的调节。HIF-1α 的稳定会激活参与致癌关键途径的基因转录,如血管生成、去分化和侵袭。自二十多年前发现以来,HIF-1α 已成为分子研究的热门话题,不仅与疾病病理学有关,而且与预后有关。在这篇综述中,我们将重点介绍 HIF-1α 调节、功能和基因表达的最新见解。我们还将讨论关于 HIF 参与癌症预后和治疗干预的新数据。